Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
Although a study on the benefits of geriatric assessment in older patients with cancer did not demonstrate significant improvements to quality of life, researchers said it yielded valuable insights ...
Older adults are at increased risk for developing cancer. They are also at increased risk for experiencing treatment toxicity. A key determinant in evaluating whether an older adult can tolerate ...
Although concurrent chemoradiotherapy (cCRT) increases survival in patients with inoperable, locally advanced non-small-cell lung cancer (NSCLC), there is no consensus on the treatment of elderly ...
Older patients are less likely to receive standard treatments for cancer than similar younger patients. Arti Hurria proposes a specific oncology geriatric assessment, including functional status, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results